Join the Nirmatrelvir / ritonavir group to help and get support from people like you.
Nirmatrelvir / ritonavir News
Extended Nirmatrelvir/Ritonavir Beneficial for Some With Long COVID
WEDNESDAY, Jan. 8, 2025 – Extended-course nirmatrelvir/ritonavir yields a meaningful reduction in symptoms for some patients with long COVID, but not all benefits persist, according to a case series...
FDA Approves Paxlovid (nirmatrelvir tablets and ritonavir tablets) for Adult Patients at High Risk of Progression to Severe COVID-19
NEW YORK--(BUSINESS WIRE) May 25, 2023 – Pfizer Inc. (NYSE: PFE) announced today that the U.S. Food and Drug Administration (FDA) approved Paxlovid™ (nirmatrelvir tablets and ritonavir tablets) for t...